Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous LNG/EE in PMDD
NCT00195559Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) comparing Levonorgestrel/Ethinyl Estradiol with Placebo (2 arms). Primary endpoint: Mean change in average Daily Record of Severity of Problems (DRSP) 21-item total daily score at 112 days. Started Sep 2005; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00195559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195559.